Trial intelligence / Profile preview

Safety and Intake Effect of EPs® 7630 in Common Cold

NCT02174653Phase 3Completed

Sponsor
Dr. Willmar Schwabe
Start
Mar 2014
Primary completion
Jul 2015
Modality
HM (Herbal Medicine)
Countries
1
01

Overview

A Phase 3 trial of pelargonium sidoides extract in common cold, sponsored by Dr. Willmar Schwabe. Started Mar 2014; status: completed.

02

Drugs

pelargonium sidoides extract
03

Conditions

common cold

Beyond the preview

Go deeper on NCT02174653.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02174653.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call